Overview
Tariq Satti practices in Islamabad, Pakistan. Mr. Satti is rated as an Experienced expert by MediFind in the treatment of Pure Red Cell Aplasia. His top areas of expertise are Aplastic Anemia, Anemia, Aase Syndrome, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.
His clinical research consists of co-authoring 26 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pure Red Cell Aplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Aase SyndromeMr. Satti isAdvanced. Learn about Aase Syndrome.
- AnemiaMr. Satti isAdvanced. Learn about Anemia.
- Aplastic AnemiaMr. Satti isAdvanced. Learn about Aplastic Anemia.
- Bone Marrow TransplantMr. Satti isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Beta ThalassemiaMr. Satti isExperienced. Learn about Beta Thalassemia.
- Congenital Aplastic AnemiaMr. Satti isExperienced. Learn about Congenital Aplastic Anemia.
- Congenital Hemolytic AnemiaMr. Satti isExperienced. Learn about Congenital Hemolytic Anemia.
- Erythema MultiformeMr. Satti isExperienced. Learn about Erythema Multiforme.
- Fanconi AnemiaMr. Satti isExperienced. Learn about Fanconi Anemia.
- Graft Versus Host Disease (GvHD)Mr. Satti isExperienced. Learn about Graft Versus Host Disease (GvHD).